首页 / 院系成果 / 成果详情页

A multicenter, prospective real-world study of irinotecan liposome (II)-based combination regimens in patients with pancreatic ductal adenocarcinoma.  会议论文  

  • 编号:
    2AA730D43004CCD20C4E333D0BA0A806
  • 作者:
    Zhang, Taiping[1] Wang, Liwei[2] Cao, Zhe Cui, Jiujie Wu, Shikai[3] Tian, Xiaodong[4] He, Yifu[5] Zhou, JianWei[6] Yu, Xianjun[7] Peng, Zhigang[8] Qin, Yanru[9] Zhou, Xinhua[10] Tian, Yifeng[11] Tian, Jing[12] Tan, Hai Dong[13] Zhang, Wenjing[14] Liu, Hongli[15] Fan, Lingli[16] Sun, Yongkun[17] Zhao, Yupei
  • 语种:
    英文
  • 会议名称:
    JOURNAL OF CLINICAL ONCOLOGY
  • 会议地点:
    Chicago, IL
  • 收录:
  • 推荐引用方式
    GB/T 7714:
    Zhang Taiping,Wang Liwei,Cao Zhe, et al. A multicenter, prospective real-world study of irinotecan liposome (II)-based combination regimens in patients with pancreatic ductal adenocarcinoma. [J].JOURNAL OF CLINICAL ONCOLOGY,2026,44(16_SUPPL):e16399-e16399.
  • APA:
    Zhang Taiping,Wang Liwei,Cao Zhe,Cui Jiujie,&Zhao Yupei.(2026).A multicenter, prospective real-world study of irinotecan liposome (II)-based combination regimens in patients with pancreatic ductal adenocarcinoma. .JOURNAL OF CLINICAL ONCOLOGY,44(16_SUPPL):e16399-e16399.
  • MLA:
    Zhang Taiping, et al. "A multicenter, prospective real-world study of irinotecan liposome (II)-based combination regimens in patients with pancreatic ductal adenocarcinoma." .JOURNAL OF CLINICAL ONCOLOGY 44,16_SUPPL(2026):e16399-e16399.
  • 入库时间:
    2026/6/17 8:23:25
  • 更新时间:
    2026/6/17 8:23:25
浏览次数:14 下载次数:0
浏览次数:14
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部